DecisionGateway
Feed Claims Forecasts Trajectories Domains Calendar Actors Places Labs
Beta
Blog
API Sign in
HomeClaimsStrategy (Nasdaq: MSTR) will enter the MSCI November final review list on November 11, and its index seat is at risk.
prediction

Strategy (Nasdaq: MSTR) will enter the MSCI November final review list on November 11, and its index seat is at risk.

A prediction by channelpanews. Statements are as reported by the cited publishers — not verified by DecisionGateway.

Strategy(Nasdaq: MSTR)将于11月11日进入MSCI 11月最终审核名单,其指数席位面临风险
channelpanewsPublished 2026-11-11 Read source
channelpanews dossier

Discussion

0/2000 Ctrl/⌘ + Enter

More claims by channelpanews

Anthropic's offering in Japan is a "no-listing public..." (text truncated).statementBased on the number of outstanding shares listed in Tuesday's filing, the company's valuation is about $1 trillion; on a fully diluted basis, its valuation is about $1.4 trillion.statementAnthropic announced its IPO plan, intending to sell shares worth up to $64.4 billion.statementAccording to a filing submitted to Japan's Ministry of Finance, Anthropic plans to sell 38.5 million to 50 million shares to Japanese investors at a reference price range of $70 to $78 per share.statementAfter formally launching its IPO roadshow, Anthropic included the Japanese market in its financing plan.statement
All claims by channelpanews
All claims
FeedActorsForecasts